Oculis Holding AG (OCS) Retained Earnings (2021 - 2026)

Oculis Holding AG's (OCS) quarterly Retained Earnings came in at -$527.9 million in Q1 2026, down 48.88% year-on-year from -$1.0 billion in Q1 2025, and down 9.72% quarter-over-quarter from -$481.1 million in Q4 2025.

Oculis Holding AG (OCS) Retained Earnings (2021 - 2026) Analysis & Trends

Oculis Holding AG's Retained Earnings history runs 6 years deep, the most recent figure standing at -$527.9 million for Q1 2026.

  • On a quarterly basis, Retained Earnings fell 48.88% year-over-year to -$527.9 million in Q1 2026; TTM through Mar 2026 was -$527.9 million, a 48.88% decrease from a year earlier, with the FY2025 full-year figure at -$463.8 million, down 42.88% from the prior year.
  • Retained Earnings declined to -$527.9 million in Q1 2026 per OCS's latest filing, from -$481.1 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$115.2 million in Q4 2022 and bottomed at -$527.9 million in Q1 2026.
  • The 5-year median for Retained Earnings is -$296.5 million (2024), against an average of -$315.6 million.
  • Across the five-year window, Retained Earnings slumped 95.51% in 2023 and slumped 38.55% in 2024, its largest moves.
  • Year by year, Retained Earnings stood at -$115.2 million in 2022, then sank by 95.51% to -$225.2 million in 2023, then tumbled by 44.73% to -$326.0 million in 2024, then tumbled by 47.59% to -$481.1 million in 2025, then fell by 9.72% to -$527.9 million in 2026.
  • Per Business Quant, the three latest OCS Retained Earnings figures stand at -$527.9 million (Q1 2026), -$481.1 million (Q4 2025), and -$451.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -527.87 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -27.89 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -279.01 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 12.91 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 14.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 11.90 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -622,000.00
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn -24.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -527.87 Mn
Dec 31, 2025 -481.09 Mn
Sep 30, 2025 -451.29 Mn
Jun 30, 2025 -415.69 Mn
Mar 31, 2025 -354.55 Mn
Dec 31, 2024 -325.97 Mn
Sep 30, 2024 -296.52 Mn
Jun 30, 2024 -261.75 Mn
Mar 31, 2024 -247.32 Mn
Dec 31, 2023 -225.22 Mn
Sep 30, 2023 -212.03 Mn
Jun 30, 2023 -188.93 Mn
Dec 31, 2022 -115.20 Mn
Dec 31, 2021 -78.39 Mn